These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2130801)

  • 21. Adansonian study of Candida albicans: intraspecific homogeneity excepting C. stellatoidea strains.
    Kamiyama A; Niimi M; Tokunaga M; Nakayama H
    J Med Vet Mycol; 1989; 27(4):229-41. PubMed ID: 2677300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medical importance of yeast killer toxin].
    Cerikcioğlu N
    Mikrobiyol Bul; 2003; 37(2-3):215-21. PubMed ID: 14593905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-constituent polyamines in Candida species and new biotyping of Candida albicans, Candida tropicalis and Candida parapsilosis strains.
    Bezjak V; al-Nakib T; Chandy R; Verghese R
    J Med Vet Mycol; 1990; 28(4):267-73. PubMed ID: 2269908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of microsatellite markers of Candida albicans used for rapid typing.
    Botterel F; Desterke C; Costa C; Bretagne S
    J Clin Microbiol; 2001 Nov; 39(11):4076-81. PubMed ID: 11682532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.
    Magliani W; Conti S; Salati A; Vaccari S; Ravanetti L; Maffei DL; Polonelli L
    FEMS Yeast Res; 2004 Oct; 5(1):11-8. PubMed ID: 15381118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variations of enzymatic activity and biotypes of the yeast like fungi strains isolated from cancer patients.
    Lukaszuk C; Krajewska-Kułak E; Niczyporuk W; Theodosopoulou E; Hatzopulu A; Krawczuk-Rybak M; Wojtukiewicz M
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():16-9. PubMed ID: 16119617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrimination between Candida albicans and other pathogenic species of the genus Candida by their differential sensitivities to toxins of a panel of killer yeasts.
    Buzzini P; Martini A
    J Clin Microbiol; 2001 Sep; 39(9):3362-4. PubMed ID: 11526179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular typing of Candida isolates from patients hospitalized in an intensive care unit.
    Vrioni G; Matsiota-Bernard P
    J Infect; 2001 Jan; 42(1):50-6. PubMed ID: 11243754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candidal balanoposthitis in China.
    Li J; Fan SR; Liu XP; Li DM; Nie ZH; Li F; Lin H; Huang WM; Zong LL; Jin JG; Lei H; Bai FY
    Clin Infect Dis; 2008 Nov; 47(9):1119-25. PubMed ID: 18808351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study.
    Małafiej E; Adamiec AC; Tworzyańska U
    Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular identification of Candida albicans and Candida dubliniensis strains isolated from clinical samples].
    Toraman ZA; Bulut Y; Yilmaz M; Ozdarendeli A
    Mikrobiyol Bul; 2005 Apr; 39(2):199-204. PubMed ID: 16128031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans.
    Polonelli L; Fanti F; Conti S; Campani L; Gerloni M; Castagnola M; Morace G; Chezzi C
    J Immunol Methods; 1990 Sep; 132(2):205-9. PubMed ID: 2170534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype analysis of Candida albicans isolates obtained from different body locations of patients with superficial candidiasis using PCRs targeting 25S rDNA and ALT repeat sequences of the RPS.
    Hattori H; Iwata T; Nakagawa Y; Kawamoto F; Tomita Y; Kikuchi A; Kanbe T
    J Dermatol Sci; 2006 Apr; 42(1):31-46. PubMed ID: 16414246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid method for detecting and distinguishing clinically important yeasts by heteroduplex mobility assays (HMAs).
    Olicio R; Almeida CA; Seuánez HN
    Mol Cell Probes; 1999 Aug; 13(4):251-5. PubMed ID: 10441196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mycological monitoring of Candida albicans infections in various hospital care units. Molecular typing of isolated strains and epidemiological survey].
    Arnavielhe S; Blancard A; Mallié M; Gouin F; Ottomani A; Manelli JC; Bastide JM
    Pathol Biol (Paris); 1996 May; 44(5):447-51. PubMed ID: 8758492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimisation of Candida albicans typing by pulsed-field gel electrophoresis.
    Hong E; Leung P
    Br J Biomed Sci; 1998 Dec; 55(4):231-7. PubMed ID: 10436536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High incidence of sensitivity to yeast killer toxins among Candida and Torulopsis isolates of human origin.
    Middelbeek EJ; Hermans JM; Stumm C; Muytjens HL
    Antimicrob Agents Chemother; 1980 Mar; 17(3):350-4. PubMed ID: 7191690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between natural reactivity (NR) against Candida albicans and natural killer (NK) activity against YAC-1 tumour cells.
    Bistoni F; Baccarini M; Blasi E; Riccardi C; Favalli C
    Int J Tissue React; 1983; 5(1):73-84. PubMed ID: 6345429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease.
    Standaert-Vitse A; Jouault T; Vandewalle P; Mille C; Seddik M; Sendid B; Mallet JM; Colombel JF; Poulain D
    Gastroenterology; 2006 May; 130(6):1764-75. PubMed ID: 16697740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hydrophobic properties of Candida sp. comparing the two methods].
    Ciok-Pater E; Gospodarek E; Prazyńska M
    Med Dosw Mikrobiol; 2008; 60(3):243-51. PubMed ID: 19143178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.